Literature DB >> 6194919

Progesterone receptor measurement by isoelectric focusing: a potential microassay.

R N Harland, E Hayward, D M Barnes.   

Abstract

Sixty-two selected breast cancers were used to compare the conventional dextran-coated charcoal (DCC) assay with a new method of separating progesterone receptor by isoelectric focusing in flat beds of agarose gel. Ninety assays were performed. Isoelectric focusing indicated correctly the presence of receptor in 92% and the absence of receptor in 86% of assays, when compared with the DCC assay. The relationship between the results of the two methods was linear. Isoelectric focusing underestimated receptor to a variable extent, finding relatively less receptor at higher absolute levels of binding than at lower levels. The lower limit of sensitivity of isoelectric focusing was 30 fmol/ml cytosol. The protein concentrations of cytosols prepared from 46 needle biopsy samples (mean weight 25 mg) ranged from 0.5 to 30 g/l (median 4 g/l, 10th percentile 0.75 g/l). Isoelectric focusing is a satisfactory method of progesterone receptor measurement and can be applied to samples too small for conventional techniques.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6194919     DOI: 10.1016/0009-8981(83)90401-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.

Authors:  A D Baildam; J Zaloudik; A Howell; D M Barnes; L Turnbull; R Swindell; M Moore; R A Sellwood
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

2.  Effect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast.

Authors:  A D Baildam; J Zaloudik; A Howell; D M Barnes; M Moore; R A Sellwood
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

3.  The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast.

Authors:  G Williams; A Howell; M Jones
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.